Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001753926-24-001882
Filing Date
2024-11-13
Accepted
2024-11-13 16:05:24
Documents
1
Group Members
3I MANAGEMENT LLCMAIER JOSHUA TARLOWTIKKUN CAPITAL LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A g084549_sc13ga.htm SC 13G/A 93656
  Complete submission text file 0001753926-24-001882.txt   95320
Mailing Address 140 BROADWAY 38TH FLOOR NEW YORK NY 10005
Business Address 874 WALKER ROAD SUITE C DOVER DE 19904 (646) 845-0040
3i, LP (Filed by) CIK: 0001841619 (see all company filings)

EIN.: 843800874 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902
Business Address 685 US HIGHWAY ONE NORTH BRUNSWICK NJ 08902 9176446313
Chromocell Therapeutics Corp (Subject) CIK: 0001919246 (see all company filings)

EIN.: 863335449 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-94460 | Film No.: 241454041
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)